Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1174P is a **pseudogene** corresponding to U6 small nuclear RNA, a non-coding RNA component of the spliceosome involved in pre-mRNA splicing[4][7]. Pseudogenes such as RNU6-1174P are DNA sequences similar to known genes (in this case, the active gene for U6 snRNA), but they do not produce functional RNA or protein due to mutations, truncation, or other sequence changes[7]. Unlike the canonical U6 snRNA, which plays an essential role in spliceosome catalytic activity and intron removal from pre-mRNA[1][3], RNU6-1174P does not participate in these biochemical processes and is not a recognized drug target or molecular biomarker. Multiple U6 snRNA pseudogenes exist in the human genome, and while their presence reflects the evolutionary importance of U6 snRNA, they themselves are generally functionally inert[3][7][4].
None (no mechanism of action; no drugs target this pseudogene[4])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1174, pseudogene (RNU6-1174P).